These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 4418757

  • 1. Structure-activity relationships in psychotomimetic phenylalkylamines.
    Aldous FA, Barrass BC, Brewster K, Buxton DA, Green DM, Pinder RM, Rich P, Skeels M, Tutt KJ.
    J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
    [No Abstract] [Full Text] [Related]

  • 2. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T.
    Seishin Shinkeigaku Zasshi; 1974 Oct; 76(2):103-28. PubMed ID: 4472773
    [No Abstract] [Full Text] [Related]

  • 3. Potential psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene analogs.
    Barfknecht CF, Nichols DE, Rusterholz DB, Long JP, Engelbrecht JA, Beaton JM, Bradley RJ, Dyer DC.
    J Med Chem; 1973 Jul; 16(7):804-8. PubMed ID: 4725926
    [No Abstract] [Full Text] [Related]

  • 4. QSAR studies on psychotomimetic phenylalkylamines.
    Gupta SP, Handa A, Bindal MC, Singh P.
    Arzneimittelforschung; 1983 Jul; 33(8):1089-90. PubMed ID: 6685483
    [Abstract] [Full Text] [Related]

  • 5. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
    Nichols DE, Pfister WR, Yim GK.
    Life Sci; 1978 Jun 26; 22(24):2165-70. PubMed ID: 672453
    [No Abstract] [Full Text] [Related]

  • 6. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB, Hine B, Gershon S.
    Eur J Pharmacol; 1974 Nov 26; 29(1):89-92. PubMed ID: 4435048
    [No Abstract] [Full Text] [Related]

  • 7. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA, Gormezano I, Cool VA.
    J Pharmacol Exp Ther; 1982 May 26; 221(2):289-94. PubMed ID: 6122729
    [No Abstract] [Full Text] [Related]

  • 8. [Electrographic and behavioral effects of various hallucinogens in the free cat].
    Rougeul A, Verdeaux J, Letalle A.
    Rev Neurol (Paris); 1969 Jun 26; 120(6):391-4. PubMed ID: 5379317
    [No Abstract] [Full Text] [Related]

  • 9. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL, Trulson ME, Stark AD, Christoph GR.
    Commun Psychopharmacol; 1977 Jun 26; 1(3):243-54. PubMed ID: 272265
    [No Abstract] [Full Text] [Related]

  • 10. Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats.
    Domino EF, Bartolini A.
    Neuropharmacology; 1972 Sep 26; 11(5):703-13. PubMed ID: 4670597
    [No Abstract] [Full Text] [Related]

  • 11. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS.
    Biol Psychiatry; 1973 Apr 26; 6(2):177-80. PubMed ID: 4709133
    [No Abstract] [Full Text] [Related]

  • 12. Stereospecific requirements for hallucinogenesis.
    Shulgin AT.
    J Pharm Pharmacol; 1973 Mar 26; 25(3):271-2. PubMed ID: 4146335
    [No Abstract] [Full Text] [Related]

  • 13. Psychomimetic methylamphetamine derivatives.
    Knoll J, Vizi ES, Ecseri Z.
    Arch Int Pharmacodyn Ther; 1966 Feb 26; 159(2):442-51. PubMed ID: 5916746
    [No Abstract] [Full Text] [Related]

  • 14. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
    Nichols DE, Barfknecht CF, Long JP, Standridge RT, Howell HG, Partyka RA, Dyer DC.
    J Med Chem; 1974 Feb 26; 17(2):161-6. PubMed ID: 4809251
    [No Abstract] [Full Text] [Related]

  • 15. The pharmacology of hallucinogens.
    Brawley P, Duffield JC.
    Pharmacol Rev; 1972 Mar 26; 24(1):31-66. PubMed ID: 4626282
    [No Abstract] [Full Text] [Related]

  • 16. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
    Wallach MB, Friedman E, Gershon S.
    J Pharmacol Exp Ther; 1972 Jul 26; 182(1):145-54. PubMed ID: 4261221
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
    Buyniski JP, Smith ML, Bierwagen ME.
    Res Commun Chem Pathol Pharmacol; 1974 Jun 26; 8(2):213-21. PubMed ID: 4859236
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
    Nichols DE, Hoffman AJ, Oberlender RA, Riggs RM.
    J Med Chem; 1986 Feb 26; 29(2):302-4. PubMed ID: 3950910
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin.
    Huang JT, Ho BT.
    Can J Physiol Pharmacol; 1973 Dec 26; 51(12):976-80. PubMed ID: 4777246
    [No Abstract] [Full Text] [Related]

  • 20. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
    Nichols DE.
    J Theor Biol; 1976 Jun 26; 59(1):167-77. PubMed ID: 7711
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.